Why has Johnson & Johnson paused Covid-19 Vaccine Trial?
Johnson & Johnson, is an American multinational corporation that develops medical devices, pharmaceutical, and consumer packaged goods, has temporarily stopped its Covid-19 vaccine candidate clinical trials, including the Phase 3 ENSEMBLE trial, because one its participants became sick after injecting the vaccine.
Due to the pause, the online enrollment system has been closed for the 60,000-patient clinical trial while the independent patient safety committee is convened.
The illness of the participant is being examined by an independent data and safety monitoring board as well as the company's clinical and safety physicians.
Johnson & Johnson said, this kind of pause is not a big deal, such pauses are normal in big trials when tens of thousands of people involve.
Last month, J & J said, its vaccine for covid-19 produced a strong immune response after that the company started its a final 60,000-person trial. The final result of this trial is expected to be declared by the end of 2020 or early 2021.
Related Posts
Subscribe Our Newsletter
0 Response to "Why has Johnson & Johnson paused Covid-19 Vaccine Trial?"
Post a Comment